Improving smoking cessation support for bladder cancer patients
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer
This study is looking at how to better help bladder cancer patients quit smoking by understanding what works, what doesn’t, and what gets in the way, so we can create more effective support for them to successfully stop smoking and improve their health.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10914874 on NIH RePORTER |
What this research studies
This research focuses on enhancing smoking cessation treatment specifically for patients diagnosed with bladder cancer. It aims to identify current practices in delivering smoking cessation support and the factors that hinder effective treatment. By using both quantitative and qualitative methods, the research will explore the barriers to quitting smoking and adapt existing strategies to better meet the needs of these patients. The ultimate goal is to increase the number of bladder cancer patients who successfully quit smoking, thereby improving their overall health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with bladder cancer who are current smokers.
Not a fit: Patients who have never smoked or those who have already successfully quit smoking prior to their diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and survival rates for bladder cancer patients who smoke.
How similar studies have performed: Previous research has shown that targeted smoking cessation interventions can lead to improved outcomes for cancer patients, indicating a promising approach in this area.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Matulewicz, Richard Steven — Sloan-Kettering Inst Can Research
- Study coordinator: Matulewicz, Richard Steven
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.